109 related articles for article (PubMed ID: 12506247)
1. [Efficacy and safety of long-term lamivudine therapy in the patients with decompensated liver cirrhosis secondary to hepatitis B].
Park TW; Park YM; Bae SH; Jang JW; Nam SW; Choi JY; Yoon SK; Cho SH; Yang JM; Han NI; Ahn BM; Lee YS; Lee CD; Park DH
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):428-35. PubMed ID: 12506247
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea].
Jung S; Suh DJ; Park HJ; Park YH; Song HG; Lee HC; Chung YH; Lee YS
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):418-27. PubMed ID: 12506246
[TBL] [Abstract][Full Text] [Related]
3. Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis.
Bae SH; Yoon SK; Choi JY; Jang JW; Cho SH; Yang JM; Han NI; Ahn BM; Chung KW; Sun HS
J Gastroenterol Hepatol; 2005 Oct; 20(10):1527-32. PubMed ID: 16174069
[TBL] [Abstract][Full Text] [Related]
4. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.
Yao FY; Terrault NA; Freise C; Maslow L; Bass NM
Hepatology; 2001 Aug; 34(2):411-6. PubMed ID: 11481627
[TBL] [Abstract][Full Text] [Related]
5. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
Viganò M; Colombo M; Aroldi A; Lunghi G; Manenti E; Ponticelli C; Lampertico P
Antivir Ther; 2005; 10(6):709-13. PubMed ID: 16218169
[TBL] [Abstract][Full Text] [Related]
6. Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B.
Nikolaidis N; Vassiliadis T; Giouleme O; Tziomalos K; Grammatikos N; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis N
Clin Transplant; 2005 Jun; 19(3):321-6. PubMed ID: 15877792
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease].
Moon W; Choi MS; Moon YM; Paik SW; Lee JH; Koh KC; Yoo BC; Rhee JC; Shim SG
Korean J Hepatol; 2005 Jun; 11(2):125-34. PubMed ID: 15980671
[TBL] [Abstract][Full Text] [Related]
9. Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
Zhang FK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):10-5. PubMed ID: 16481275
[TBL] [Abstract][Full Text] [Related]
10. A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
Nishida T; Kobashi H; Fujioka S; Fujio K; Takaguchi K; Ikeda H; Kawaguchi M; Ando M; Araki Y; Higashi T; Shoji B; Takaki A; Iwasaki Y; Sakaguchi K; Shiratori Y; Yamamoto K
J Gastroenterol Hepatol; 2008 May; 23(5):794-803. PubMed ID: 18086120
[TBL] [Abstract][Full Text] [Related]
11. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
Jonas MM; Little NR; Gardner SD;
J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241
[TBL] [Abstract][Full Text] [Related]
12. A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection.
Sharma YR; Miah AR; Saha SK; Mohammed S; Rahman M; Roy PK; Hasan M
Nepal Med Coll J; 2004 Dec; 6(2):106-11. PubMed ID: 16295739
[TBL] [Abstract][Full Text] [Related]
13. The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis.
Kilic ZM; Kuran S; Akdogan M; Cicek B; Oguz D; Odemis B; Sasmaz N
Adv Ther; 2008 Mar; 25(3):190-200. PubMed ID: 18385953
[TBL] [Abstract][Full Text] [Related]
14. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
15. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis.
Ooga H; Suzuki F; Tsubota A; Arase Y; Suzuki Y; Akuta N; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Kumada H
J Gastroenterol; 2004 Nov; 39(11):1078-84. PubMed ID: 15580401
[TBL] [Abstract][Full Text] [Related]
17. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
Hann HW; Fontana RJ; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Gardner SD; Brown N; Griffiths D;
Liver Transpl; 2003 Jan; 9(1):49-56. PubMed ID: 12514773
[TBL] [Abstract][Full Text] [Related]
18. Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.
Cetin K; Sabahattin K; Kadir D; Ahmet D; Ziyaettin D; Selim B; Mürüvvet B; Fatih B; Güngör B; Zeynel M; Yilmaz C; Atilla O
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcv-ccxcvii. PubMed ID: 15244206
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
Manolakopoulos S; Bethanis S; Elefsiniotis J; Karatapanis S; Triantos C; Sourvinos G; Touloumi G; Economou M; Vlachogiannakos J; Spandidos D; Avgerinos A; Tzourmakliotis D
Aliment Pharmacol Ther; 2006 Mar; 23(6):787-95. PubMed ID: 16556181
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of 153 patients with decompensated hepatitis B virus-related cirrhosis is improved after 3-year continuous lamivudine treatment.
Chen GC; Yu T; Min XH; Zhao LN; Qing Q; Yuan YH; Su H; Zhan J; Huang KH; Chen QK
Chin Med J (Engl); 2013; 126(8):1538-43. PubMed ID: 23595391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]